https://prabadinews.com/
  • October 7, 2026
  • Last Update July 17, 2026 9:28 pm
  • United States of America

FDA Grants Full Approval to mRNA-1273 COVID-19 Vaccine in Children At Increased Risk

FDA Grants Full Approval to mRNA-1273 COVID-19 Vaccine in Children At Increased Risk

mRNA-1273, marketed as Spikevax by Moderna, is now fully approved for individuals aged 6 months through 64 years with high-risk features for severe COVID-19.

administrator

Related Articles